Julphar Ethiopia Oral and Topical Preparations
Annual capacities: 500 million tablets, 100 million capsules, 15 million bottles of syrups and suspensions, 2 million tubes of ointments
Taking into consideration the potential economic growth in Ethiopia, Julphar has decided to build the first of its kind pharmaceutical plant in Africa. Julphar Ethiopia was inaugurated in 2013. It produces and distributes pharmaceutical products to the Ethiopian market – such as antibacterial, cough preparations, antidiabetic, diuretics and anti-allergic. Tablets, capsules, syrups, suspensions and ointments are the dosage forms manufactured in the factory. Recently, Julphar Ethiopia has received the PIC/S GMP certification, which has confirmed the high quality of its manufactured products, and has signed a Memorandum of Understanding (MoU) with the Ethiopian Ministry of Health to supply Hepatitis C medicines. Julphar Ethiopia has become a land mark in Addis Ababa and a model to follow.